We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Bionanomatrix Awarded $397,750 NIH Grant

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

BioNanomatrix LLC has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). 

The two-year $397,750 Small Business Investment Research (SBIR) grant was awarded under the NIH BioEngineering Nanotechnology Initiative.

"We are delighted that the NIH has again recognized the potential of our revolutionary whole genome analysis technology by awarding us this second major grant explicitly intended to support the development and commercialization of our integrated nanofluidics platform," said Michael Boyce-Jacino, Ph.D., president and CEO of BioNanomatrix.

"This support will enable us to accelerate development of our platform, which we believe represents a breakthrough in genomic analysis capabilities with broad utility and large commercial potential."

BioNanomatrix is developing integrated systems that enable nanoscale single molecule identification and analysis of the entire genome, delivering single molecule sensitivity with haplotyping capability in a parallel format. 

"The nanochannel array technology we are developing with this funding is designed to permit direct visualization and analysis of multi-megabase fragments of DNA at the single molecule level with high feature resolution, allowing researchers to visualize mutations, haplotypes, epigenetic features and even DNA-protein binding events," said Han Cao, Ph.D., chief scientific officer of BioNanomatrix and the principal investigator on this grant. 

"We believe our technology represents a major advance beyond what is available today, and we are pleased that this new grant will help speed its development."